Efficacy of early immunomodulator therapy on the outcomes of Crohn’s disease

BACKGROUND: The natural course of Crohn’s disease (CD), with continuing relapses and remissions, leads to irreversible intestinal damage. Early adoption of immunomodulator therapy has been proposed in order to address this; however, it is still uncertain whether early immunomodulator therapy could a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwak, Min Seob, Kim, Duk Hwan, Park, Soo Jung, Kim, Tae Il, Hong, Sung Pil, Kim, Won Ho, Cheon, Jae Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4017088/
https://www.ncbi.nlm.nih.gov/pubmed/24886458
http://dx.doi.org/10.1186/1471-230X-14-85

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4017088/
https://www.ncbi.nlm.nih.gov/pubmed/24886458
http://dx.doi.org/10.1186/1471-230X-14-85

Ejemplares similares